 | Up a level |
Cheung, K. L., Evers, S. M. A. A., De Vries, H., Levy, P., Pokhrel, S., Jones, T., Danner, M., Wentlandt, J., Knufinke, L., Mayer, S. and Hiligsmann, M. (2018). Most important barriers and facilitators of HTA usage in decision-making in Europe. Expert Rev. Pharmacoecon. Outcomes Res., 18 (3). S. 297 - 305. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1744-8379
Danner, M., Mueller, D., Schmutzler, R., Rhiem, K., Engel, C., Stollenwerk, B., Stock, S. and Wassermann, K. (2016). ECONOMIC MODELING OF RISK-ADAPTED SCREEN-AND-TREAT STRATEGIES IN WOMEN AT HIGH-RISK FOR BREAST OR OVARIAN CANCER. Value Health, 19 (7). S. A737 - 2. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1524-4733
Gutknecht, M., Danner, M. and Augustin, M. (2016). USING ANALYTIC HIERARCHY PROCESS TO WEIGHT PATIENT-RELEVANT OUTCOMES IN THE TREATMENT OF PSORIASIS FOR CALCULATING THE PATIENT BENEFIT INDEX. Value Health, 19 (7). S. A389 - 2. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1524-4733
Gutknecht, M., Schaarschmidt, M. L., Danner, M. and Augustin, M. (2017). Which Therapeutic Goals do Patients prefer with Psoriasis? Results of a Method Comparison. J. Dtsch. Dermatol. Ges., 15. S. 126 - 128. HOBOKEN: WILEY. ISSN 1610-0387
Stock, S. and Danner, M. (2014). Does the elicitation of stakeholder attitudes and preferences add valuable information to small-area analyses? A health policy perspective. Bundesgesundheitsblatt-Gesund., 57 (2). S. 188 - 197. NEW YORK: SPRINGER. ISSN 1437-1588
Vennedey, V., Danner, M., Civello, D., Schwalm, A., Seidl, A. and Hiligsmann, M. (2016). PATIENTS' PREFERENCES FOR CHARACTERISTICS OF PERIODONTAL DISEASE AND ITS' TREAT MENT: A DISCRETE CHOICE EXPERIMENT. Value Health, 19 (7). S. A352 - 2. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1524-4733